Thyroid nodules: A review of current guidelines, practices, and prospects

European Journal of Endocrinology

Volumn 159, Issue 5, 2008, Pages 493-505

  Gharib, H ^a   Papini, E ^b   Paschke, R ^c  

^a MAYO CLINIC   (United States)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; THYROTROPIN; THYROXINE;

ASPIRATION BIOPSY; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ECHOGRAPHY; EUROPE; EVIDENCE BASED PRACTICE; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HUMAN; INCIDENCE; LABORATORY TEST; MEDICAL EXPERT; MEDICAL SOCIETY; MORBIDITY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID NODULE; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT INDICATION;

ENDOCRINOLOGY; HUMANS; PRACTICE GUIDELINES AS TOPIC; THYROID NODULE;

EID: 56749156657     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0135     Document Type: Review

References (53)

1. American Association of Clinical Endocrinologists and Associazione Medici. Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocrine Practice 2006 12 63-102.
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI & Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 16 109-142.
3. Pacini E, Schlumberger M, Dralle H, Elisei R, Smit JW & Wiersinga W. European Consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 2006 154 787-803.
4. Brander A, Viikinkoski P, Tuuhea J, Voutilainen L & Kivisaari L. Clinical versus ultrasound examination of the thyroid gland in common clinical practice. Journal of Clinical Ultrasound 1992 20 37-42.
5. Ezzat S, Sarti DA, Cain DR & Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Archives of Internal Medicine 1994 154 1838-1840.
6. Mortensen JD, Woolner LB & Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. Journal of Clinical Endocrinology and Metabolism 1955 15 1270-1280.
7. Volzke H, Ludemann J, Robinson DM, Spieker KW Schwahn C, Kramer A, John U & Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003 13 803-810.
8. Nagataki S & Nystrom E. Epidemiology and primary prevention of thyroid cancer. Thyroid 2002 12 889-896.
9. Davies L & Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 2006 295 2164-2167.
10. Colonna M, Guizard AV, Schvartz C, Velten M, Raverdy N, Molinie F, Delafosse P, Franc B & Grosclaude P. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). European Journal of Cancer 2007 43 891-900.
11. Krebs in Deutschland, Häufigkeiten und Trends. 2006. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.(GEKID) in Zusammenarbeit mit dern Robert Koch Institut (RKI).
12. Harach HR, Franssila KO & Wasenius VM. Occult papillary carcinoma of the thyroid. A 'Normal' finding in Finland. A systematic autopsy study. Cancer 1985 56 531-538.
13. Brauer VF, Hentschel B & Paschke R. Euthyroid thyroid nodules, aims, results and perspectives concerning drug therapy. Deutsche Medizinische Wochenschrift 2003 128 2381-2387.
14. Lang W, Borrusch H & Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. American Journal of Clinical Pathology 1988 90 72-76.
15. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C & Ballestin-Carcavilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 1993 71 4022-4029.
16. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE & Degli Uberti EC. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. Journal of Clinical Endocrinology and Metabolism 2006 91 2171-2178.
17. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H & Jorgensen T. Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. European Journal of Endocrinology 2000 142 224-230.
18. Belfiore A, La Rosa CL, Padova G, Sava L, Ippolito O & Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 1987 60 3096-3102.
19. Bahre M, Hilgers R, Lindemann C & Emrich D. Thyroid autonomy: sensitive detection in vivo and estimation of its functional relevance using quantified high-resolution scintigraphy. Acta Endocrinologica 1988 117 145-153.
20. Krohn K, Wohlgemuth S, Gerber H & Paschke R. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. Journal of Pathology 2000 192 37-42.
21. Laurberg F, Pedersen KM, Vestergaard H & Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 1991 229 415-420.
22. Emrich D, Erlenmaier U, Pohl M & Luig H. Determination of the autonomously functioning volume of the thyroid. European Journal of Nuclear Medicine 1993 20 410-414.
23. Bennedback FN, Perrild H & Hegedus L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European Survey. Clinical Endocrinology 1999 50 357-363.
24. Bennedback FN & Hegedus L. Management of the solitary thyroid nodule: results of a North American Survey. Journal of Clinical Endocrinology and Metabolism 2000 85 2493-2498.
25. Fuhrer D, Mugge C & Paschke R. Questionnaire on management of nodular thyroid disease (Annual Meeting of the Thyroid Section of the German Society of Endocrinology 2003). Experimental and Clinical Endocrinology and Diabetes 2005 113 152-159.
26. Paschke R, Reiners C, Fuhrer D, Schmid KW Dralle H & Brabant G. Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Opinion of the Thyroid Section of the German Society for Endocrinology. Deutsche Medizinische Wochenschrift 2005 130 1831-1836.
27. Gharib H & Papim E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinology and Metabolism Clinics of North America 2007 36 707-735 (vi).
28. Diehl LA, Garcia V, Bonnema SJ, Hegedus L, Albino CC & Graf H. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an Electronic Survey. Journal of Clinical Endocrinology and Metabolism 2005 90 117-123.
29. Wiersinga WM. Is repeated fine-needle aspiration cytology indicated in (benign) thyroid nodules? European Journal of Endocrinology 1995 132 661-662.
30. Lucas A, Llatjos M, Salinas I, Reverter J, Pizarro E & Sanmarti A. Fine-needle aspiration cytology of benign nodular thyroid disease. Value of re-aspiration. European Journal of Endocrinology 1995 132 677-680.
31. Chehade JM, Silverberg AB, Kim J, Case C & Mooradian AD. Role of repeated ftne-needle aspiration of thyroid nodules with benign cytologic features. Endocrine Practice 2001 7 237-243.
32. Richter B, Neises G & Clar C. Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis. Endocrinology and Metabolism Clinics of North America 2002 31 699-722.
33. Paphavasit A, Thompson GB, Hay ID, Grant CS, van Heerden JA, Ilstrup DM, Schleck C & Goellner JR. Follicular and Hurthle cell thyroid neoplasms. is frozen-section evaluation worthwhile? Archives of Surgery 1997 132 674-678.
34. Cheung K, Roman SA, Wang TS, Walker HD & Sosa JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. Journal of Clinical Endocrinology and Metabolism 2008 93 2173-2180.
35. Bhagat MC, Dhaliwal SS, Bonnema SJ, Hegedus L & Walsh JP. Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre. British Journal of Surgery 2003 90 1103-1112.
36. Borget I, De Pouvourville G & Schlumberger M. Editorial: calcitonin determination in patients with nodular thyroid disease. Journal of Clinical Endocrinology and Metabolism 2007 92 425-427.
37. Hodak SP & Burman KD. The Calcitonin Conundrum - is it time for routine measurement of serum calcitonin in patients with thyroid nodules? Journal of Clinical Endocrinology and Metabolism 2004 89 511-514.
38. American Association of Clinical Endocrinologists. Protocol for Standardized Production of Clinical Practice Guidelines. Endocrine Practice 2004 10 353-361.
39. US Preventive Services Task Force Ratings: strength of recommendations and quality of evidence. Guide to clinical preventive services, Third edition: periodic updates, 2000-2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/ratings.htm.
40. National Comprehensive Cancer Network. Thyroid Cancer. http://www.nccn.org/professionals/physician_gls/PDF/thyroid. Accessed December 1, 2007.
41. British Thyroid Association & Royal College of Physicians. Guidelines for management of thyroid cancer. http://www.btf-hyroid.org/ Accessed December 1, 2007.
42. AGREE collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. http://www.agreecollaboration.org. Accessed November 24, 2007.
43. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES & Mandel SJ. Usefulness of ultrasonography in the management of nodular thyroid disease. Annals of Internal Medicine 2000 133 696-700.
44. Tan GH, Gharib H & Reading CC. Solitary thyroid nodule. Comparison between palpation and ultrasonography. Archives of Internal Medicine 1995 155 2418-2423.
45. Hagag P, Strauss S & Weiss M. Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 1998 8 989-995.
46. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E & Conte-Devolx B. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. Journal of Clinical Endocrinology and Metabolism 1997 82 338-341.
47. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A & Pacini F. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. Journal of Clinical Endocrinology and Metabolism 2004 89 163-168.
48. Pacini F. Burroni L, Ciuoli C, Di Cairano G & Guarino E. Management of thyroid nodules: a clinicopathological, evidence-based approach. European Journal of Nuclear Medicine and Molecular Imaging 2004 31 1443-1449.
49. Zelmanovitz F, Genro S & Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. Journal of Clinical Endocrinology and Metabolism 1998 83 3881-3885.
50. Wemeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C & Vlaeminck-Guillem V. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. Journal of Clinical Endocrinology and Metabolism 2002 87 4928-4934.
51. Castro MR, Caraballo PJ & Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2002 87 4154-4159.
52. www.british-thyroid-association.org.
53. Solomon BL, Wartofsky L & Burman KD. Current trends in the management of well differentiated papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1996 81 333-339.